© 2018 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#lamivudine

Delstrigo

ViiV’s Experimental Two-Drug Regimen Shows Promise

The combo of dolutegravir and lamivudine controlled HIV as well as a triple-drug combo of dolutegravir plus Truvada.

FDA Approves Mylan’s Cut-Price HIV Tablets Symfi Lo and Cimduo

Symfi Lo contains efavirenz, lamivudine and tenofovir disoproxil fumarate (TDF); Cimduo contains TDF and lamivudine.

Treatment: Two Drugs

ViiV Begins Phase III Trial of Two-Drug HIV Regimen

The trial will test a regimen of Tivicay (dolutegravir) plus Epivir (lamivudine) against Tivicay and Truvada (tenofovir/emtricitabine).

Switching to Two-Drug HIV Regimen Would Save Big Money

The regimen of Tivicay (dolutegravir) and Epivir (lamivudine) would be a highly cost-effective first-line option and save a great deal.

PrEP Protects Breastfeeding Infants From HIV for Up to a Year

HIV-positive women who breastfeed can protect their infants from infection for a year after birth by giving them a liquid form of PrEP.

Another Two-Drug HIV Regimen Shows Promise

A two-drug regimen of Norvir (ritonavir)–boosted Reyataz (atazanavir) and Epivir (lamivudine) treats HIV as well or better tha...

In Those With HIV, Best to Treat Hep B With Two Drugs

Among HIV-positive people, it is preferable to treat hepatitis B with a two-drug regimen rather than with monotherapy.

Certain HIV Meds Raise Risk of Heart Trouble

Various HIV antiretrovirals are linked to a raised risk of cardiovascular problems, although the overall risk of such an outcome is still low.

Individual HIV Meds Are Just as Effective as Combo Pills

Multi-antiretroviral combination tablets appear to combat HIV no better than regimens that include individual tablets.

HIV Treatment Guidelines Nix Atripla as First-Line Therapy

A revision of U.S. HIV treatment guidelines has removed Atripla (efavirenz/tenofovir/emtricitabine) from the priority list of first-line antir...

HIV Meds Early in Pregnancy Linked to Low Risk of Birth Defects

Pregnant women who take antiretrovirals (ARVs) to treat HIV early in their pregnancies appear to have a low risk of birth defects in their inf...

Epivir and Tenofovir Appear Safe to Use During Breast-Feeding

Epivir (lamivudine) and Viread (tenofovir) are likely safe for women to use while breast-feeding.

People With HIV and Kidney Problems Should Avoid Viread (Tenofovir)

While antiretroviral therapy is beneficial for HIV-positive people with reduced kidney function, they should not take Viread (tenofovir).

Atripla Is More Than the Sum of Its Three Parts

People taking Atripla reach virologic failure more slowly and are less likely to develop drug resistance than those taking an equivalent combi...
Advertisement